| Literature DB >> 28155294 |
Åsa Fahlman1, Anna Edner, Sandra Wenger, Chris Foggin, Görel Nyman.
Abstract
When immobilising wildlife, adverse side effects can include hypoxaemia, acidosis and hypertension. Pulmonary gas exchange and acid-base status were evaluated during immobilisation of 25 free-ranging and one boma-held black rhinoceros (Diceros bicornis) in Zimbabwe. The effect of different body positions on arterial oxygenation was evaluated. A combination of the following drugs was used: an opioid (etorphine or thiafentanil), azaperone and an a2 -adrenoceptor agonist (detomidine or xylazine). Respiratory and heart rates, rectal temperature and pulse oximetry-derived haemoglobin oxygen saturation were recorded. Serial arterial blood samples were analysed immediately in the field. Marked hypoxaemia and hypercapnia were recorded in immobilised free-ranging black rhinoceroses. Arterial oxygenation was higher during sternal compared to lateral recumbency. Most rhinoceroses developed acidaemia of respiratory and metabolic origin. Initially high lactate concentrations in free-ranging rhinoceroses decreased during immobilisation. Pulse oximetry was unreliable in the detection of hypoxaemia. Positioning in sternal recumbency and routine use of oxygen supplementation are recommended in the management of immobilised rhinoceroses as measures to improve arterial oxygenation.Entities:
Mesh:
Substances:
Year: 2016 PMID: 28155294 PMCID: PMC6138189 DOI: 10.4102/jsava.v87i1.1328
Source DB: PubMed Journal: J S Afr Vet Assoc ISSN: 1019-9128 Impact factor: 1.474
Immobilising drug combinations and doses used for free-ranging black rhinoceros in Zimbabwe. Doses (in mg) for black rhinoceros immobilised with etorphine, azaperone, and xylazine or detomidine.
| Age group | Sex | Etorphine | Azaperone | Xylazine | Detomidine | |
|---|---|---|---|---|---|---|
| Adult | 16 | 11 M, 5 F | 3.2–4.3 | 70–90 | 20–45 ( | 3.5–4.0 ( |
| Subadult | 2 | 2 M | 2.7–2.8 | 35–40 | 20 ( | 2.5 ( |
| Calf | 5 | 3 M, 2F | 1.0–1.7 | 15–22 | 10–13 ( | 1.0 ( |
, Age group definitions: adult > 4 years, subadult 2–4 years, calf 1–2 years;
, M, male; F, female;
, M99®, 9.8 mg etorphine HCl/mL, Novartis South Africa (Pty) Ltd., Kempton Park, South Africa;
, Stresnil®, 40 mg azaperone/mL, Janssen Animal Health, Halfway House, South Africa;
, Rompun®, 500 mg xylazine powder/vial, Bayer, Leverkusen, Germany;
, Domosedan®, 10 mg detomidine HCl/mL, Novartis South Africa (Pty) Ltd.;
, one calf did not receive an alpha-2-adrenoceptor agonist.
FIGURE 1(a–h), Arterial blood gases, pH and lactate concentration in 25 free-ranging black rhinoceroses immobilised with a combination of an opioid (thiafentanil in adult #3 and subadult #18, etorphine in the others), azaperone and an α2-agonist (xylazine or detomidine).
FIGURE 2Box-plot showing partial pressure of arterial oxygen (PaO2) (median, 25th and 75th quartiles, range) in 21 free-ranging black rhinoceroses during sternal (n = 11) or lateral (n = 10) recumbency at approximately 15 minutes after darting.
Immobilising drug combinations and doses used for free-ranging black rhinoceros in Zimbabwe. Doses (in mg) for black rhinoceros immobilised with thiafentanil, azaperone, and xylazine or detomidine.
| Age group | Sex | Thiafentanil | Azaperone | Xylazine | Detomidine | |
|---|---|---|---|---|---|---|
| Adult | 1 | 1 M | 3.0 | 90 | - | 4.5 |
| Subadult | 1 | 1 F | 2.0 | 50 | 20 | - |
, Age group definitions: adult > 4 years, subadult 2–4 years, calf 1–2 years;
, M, male; F, female;
, A3080, 10 mg thiafentanil oxalate/mL, Wildlife Pharmaceuticals Inc., Fort Collins, Colorado, USA;
, Stresnil®, 40 mg azaperone/mL, Janssen Animal Health, Halfway House, South Africa;
, Rompun®, 500 mg xylazine powder/vial, Bayer, Leverkusen, Germany;
, Domosedan®, 10 mg detomidine HCl/mL, Novartis South Africa (Pty) Ltd.